| Pfizer AG - Ruxience 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 69701 | | 01 | | Ruxience 100 mg/10 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FA01 | | | | 19.08.2024 | | |
|
| Composition |
| rituximabum 100 mg, histidinum, histidini hydrochloridum monohydricum, dinatrii edetas corresp. natrium 0.07 mg, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 10 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Rituximab | 100mg / 10ml |
| | BAG: Active Agent | Dose |
|---|
| Rituximab | 100 mg |
| | | | Inactive agents |
|---|
| Dinatrii Edetas | | Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 203.40 | 237.65 | A | SL | No |
|
